In 2024, National Health Investors completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
National Health Investors has also provided a category-level breakdown for 4 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 |
|---|---|---|
Total Scope 1 | 3,895a | 4,348a |
Total Scope 2 | ||
Unspecified Calculation Method | 3,917a | 3,961a |
Total Scope 3 | 92,857a | N/A |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 11.6206a | 13.5945a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, the total operational greenhouse gas (GHG) emissions of National Health Investors amounted to 7,812 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of National Health Investors decreased by 5.98%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2024, the total Scope 1 emissions of National Health Investors were 3,895 metric tons of CO₂ equivalent (tCO₂e).a
Compared to the previous year (2023), National Health Investors's Scope 1 emissions decreased by 10.42%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2024, National Health Investors reported Scope 2 greenhouse gas (GHG) emissions of 3,917 tCO₂e without specifying the calculation method.a
Compared to the previous year (2023), National Health Investors's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that National Health Investors's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2024, National Health Investors reported its Scope 2 emissions using an unspecified methodology.a
In 2024, National Health Investors reported 92,857 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of National Health Investors includes a breakdown across 4 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2023, reflecting improved emissions accounting practices and greater transparency across the company's value chaina
In 2024, National Health Investors reported total Scope 3 emissions of 92,857 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 0.29% of these emissions originated from upstream activities such as purchased goods and capital goods, while 99.71% came from downstream activities like product use, distribution, and end-of-life treatment.a
In 2024, National Health Investors reported emissions for 4 out of the 15 Scope 3 categories defined by the GHG Protocol.a
The limited disclosure restricts visibility into specific emission sources across the company's value chain.
In 2024, the largest contributors to National Health Investors's Scope 3 emissions were:a
In 2024, National Health Investors reported Scope 1 greenhouse gas (GHG) emissions of 3,895 tCO₂e and total revenues of USD 335 millions. This translates into an emissions intensity of 11.62 tCO₂e per millions USD.a
In 2024, National Health Investors reported a Scope 1 emissions intensity of 11.62 tCO₂e per millions USD. Compared to the peer group median of 6.17, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2024, National Health Investors ranked 13 out of 20 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
National Health Investors is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
In 2024, National Health Investors reported a total carbon footprint of 100,669 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 1,111.57% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to National Health Investors's total carbon footprint was Scope 3 emissions, accounting for 92.24% of the company's total carbon footprint, followed by Scope 2 emissions at 3.89%.a